Quality Biological Inc.

Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business based in Gaithersburg, Maryland, supplies laboratory reagents, consumables, chemicals, and biological materials to federal agencies as a prime contractor, with a dominant footprint in medical and pharmaceutical supplies distributed through blanket purchase agreements and indefinite delivery contracts. The vendor does not operate as a subcontractor; all 2,394 awards in the recent source snapshot are prime awards with no subcontract activity. Quality Biological competes full-and-open across federal customers without relying on set-aside vehicles for its primary contracting strategy, though many individual awards and the vendor's SBA designations support competitive positioning.

The vendor's customer concentration is heavily skewed toward supply-chain ordering rather than prime-contract relationships. The Defense Logistics Agency Troop Support Medical accounts for 1,318 awards (55% of total award count) but only $4.2 million in combined potential value—reflecting high-volume, low-value micro-purchase and small-order patterns. This divergence from dollar concentration is sharp: the National Institute of Allergy and Infectious Diseases (NIAID) holds only 17 awards but anchors $63.6 million in combined potential value, driven by a $25.4 million definitive contract awarded April 8, 2025, for production, procurement, storage, and maintenance of reagents and assays supporting preclinical and clinical AIDS vaccine research under a Total Small Business set-aside, cost-plus-fixed-fee pricing, and performance through April 7, 2032 at the Montgomery Village facility. The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations places 188 awards ($12.1 million combined potential value), primarily BPA calls for chemicals and laboratory supplies. The NIH Office of the Director and related components place 603 awards with $5.6 million combined potential value.

Quality Biological holds a $100 million single-award BPA with NIH's Office of Logistics and Acquisition Operations (renewed November 29, 2023, with a $10 million ceiling and completion date of November 30, 2026) and a $2 million multiple-award indefinite delivery contract with the Defense Logistics Agency Troop Support Medical group. The largest parent vehicles in the award footprint are the Defense Logistics Agency IDC SPE2DE14D0004 (1,063 task orders, $453 thousand combined potential value), the NIH BPA HHSN263200000052006B (376 task orders, $3.1 million), a second DLA IDC SPE2DE20D0001 (187 task orders, $80 thousand), and another NIH BPA HHSN263201600031B (170 task orders, $1.5 million). Quality Biological also holds a GSA Multiple Award Schedule contract, from which it placed five delivery orders in 2026 for serological pipettes, phosphate buffered saline, high purity water, and tissue culture dishes to NIH offices.

Activity levels show pronounced clustering in 2023 (30 awards) followed by sharp decline to 2 awards in 2024, 2 in 2025, and 5 in 2026 (through mid-September). The recompete cliff is minimal: only 4 awards with ultimate completion dates in the next twenty-four months carry combined potential value of $333 thousand, signaling limited near-term recompete pressure. Combined potential value across all 2,394 awards stands at $1.19 billion, with only $95.4 million obligated (8% of potential value), consistent with the predominance of small BPA calls and task orders against standing vehicles rather than large definitive contracts.

SCI-reported service-contract invoicing totals $8.7 million across FY2023–FY2025 (FY2022 reported zero), with $3.4 million invoiced in FY2023 (3.6 FTEs), $3.6 million in FY2024 (3.7 FTEs), and $1.6 million in FY2025 (1.9 FTEs). These SCI figures capture only federal service contracts above the $150 thousand reporting threshold and exclude the bulk of Quality Biological's goods and supply-chain revenue; they represent a narrow slice of the vendor's federal activity. Government-paid hourly rates on SCI-reportable prime contracts cluster tightly around a median of $466.29/hr (10th percentile $462.07/hr, 90th percentile $470.52/hr), reflecting technical labor on standing service deliverables. The vendor reports zero sub-engagement across SCI prime records, consistent with its full-delivery-team posture on the reported service work.

Quality Biological's capability framing centers on production and supply of laboratory reagents, cell culture media, buffers, biological materials, and consumables in support of biomedical research. Representative work includes the NIAID AIDS vaccine reagent production contract ($25.4 million, cost-plus-fixed-fee, through 2032); multiple NIH BPA calls for phosphate buffered saline, serological pipettes, tissue culture dishes, high purity water, and laboratory chemicals issued by the NIH Office of Logistics and Acquisition Operations (typically $10 thousand to $24 thousand per call); and purchase orders from the National Institute of Allergy and Infectious Diseases Vaccine Research Center for sterilized sheath fluid ($22.6 thousand, May 2025) and specialized cell-culture reagents. The vendor operates all work from its Gaithersburg and Montgomery Village, Maryland facilities with no teaming relationships named in the award footprint.

Quality Biological Inc. provides specialized services for federal government agencies and biotechnology organizations, ranging from reagent support for vaccine development to customized solutions for cell and molecular biology applications. Quality is our number one priority. Our Contract Services Division is a motivated team of experienced scientists and dedicated technicians who understand customers' needs for quality products and services. We are flexible, work collaboratively with our customers, and operate carefully with controlled Standard Operating Procedures.